Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve
Journal of Ocular Pharmacology and Therapeutics · 2023
DOI: 10.1089/jop.2023.0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2023. Verfasst von Lucy Joanne Kessler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Macular Edema, Uveitis, Diabetic Retinopathy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
This study investigated the impact of baseline clinical and optical coherence tomography (OCT) factors on the response to a 0.19-mg fluocinolone acetonide (FAc) implant in patients with noninfectious uveitic macular edema evaluated by the area under the curve over 24 months.
Methods
A retrospective study was conducted of eyes of patients with noninfectious uveitic macular edema undergoing FAc treatment, with follow-up from baseline to 24 months. The area under the curve (AUC) of best-corrected visual acuity (BCVA) and the central macular thickness (CMT) were calculated using the trapezoidal rule. Clinical and OCT data at the time of FAc administration were collected, and associations with AUC of BCVA and CMT changes were investigated.
Results
Twenty-three patients were enrolled. BCVA and CMT significantly improved after FAc implantation (P 0.05). The younger the patient at the time of FAc injection, the greater the reduction in CMT (coef. = 1.76, P < 0.05).
Conclusions
Among all clinical and morphological baseline factors, Baseline BCVA was the strongest predictor for AUCBCVA, while no association with baseline OCT features was observed. Overall, improvement of BCVA and CMT after FAc injection was maintained over 24 months. This study is registered in the German Clinical Trials Register under the DRKS-ID: DRKS00024399.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.
Zitieren
APA
Kessler, L. J., Auffarth, G. U., & Khoramnia, R. (2023). Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0027
Vancouver
Kessler LJ, Auffarth GU, Khoramnia R. Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. Journal of Ocular Pharmacology and Therapeutics. 2023. doi:10.1089/jop.2023.0027
BibTeX
@article{Kessler2023,
author = {Kessler, Lucy Joanne and Auffarth, Gerd Uwe and Khoramnia, Ramin},
title = {Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2023},
doi = {10.1089/jop.2023.0027}
}
EUVIMED